AGADA Biosciences

company

About

Agadabio provides of orphan drug development services provides centralized preclinical drug efficacy testing for neuromuscular disorders.

  • 11 - 50

Details

Last Funding Type
Pre-seed
Industries
Biotechnology
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
AGADA Biosciences has raised a total of — in funding over 2 rounds. Their latest funding was raised on Oct 1, 2014 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2014 Pre-seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
AGADA Biosciences is funded by 1 investors. Innovacorp are the most recent investors.
Investor Name Lead Investor Funding Round
Innovacorp Pre-seed